ALGN vs. STE, SNN, ZBH, MSA, AVNS, ESTA, INGN, EAR, EW, and COO
Should you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include STERIS (STE), Smith & Nephew (SNN), Zimmer Biomet (ZBH), MSA Safety (MSA), Avanos Medical (AVNS), Establishment Labs (ESTA), Inogen (INGN), Eargo (EAR), Edwards Lifesciences (EW), and Cooper Companies (COO).
STERIS (NYSE:STE) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.
Align Technology has lower revenue, but higher earnings than STERIS. STERIS is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.
92.9% of STERIS shares are owned by institutional investors. Comparatively, 87.1% of Align Technology shares are owned by institutional investors. 1.0% of STERIS shares are owned by company insiders. Comparatively, 0.7% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, STERIS had 3 more articles in the media than Align Technology. MarketBeat recorded 9 mentions for STERIS and 6 mentions for Align Technology. STERIS's average media sentiment score of 1.57 beat Align Technology's score of 0.60 indicating that Align Technology is being referred to more favorably in the news media.
Align Technology received 439 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 69.83% of users gave Align Technology an outperform vote while only 58.67% of users gave STERIS an outperform vote.
STERIS presently has a consensus price target of $240.60, suggesting a potential upside of 19.11%. Align Technology has a consensus price target of $336.60, suggesting a potential upside of 55.39%. Given STERIS's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than STERIS.
STERIS has a net margin of 10.52% compared to STERIS's net margin of 9.53%. Align Technology's return on equity of 13.58% beat STERIS's return on equity.
STERIS has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500.
Summary
Align Technology beats STERIS on 10 of the 18 factors compared between the two stocks.
Get Align Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Align Technology Competitors List
Related Companies and Tools